Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein

Journal of General Virology

Volumn 93, Issue PART 9, 2012, Pages 1908-1917

  Shirato, Kazuya ^a   Kawase, Miyuki ^a   Watanabe, Oshi ^b   Hirokawa, Chika ^c   Matsuyama, Shutoku ^a   Nishimura, Hidekazu ^b   Taguchi, Fumihiro ^a,d  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

^c Niigata Prefectural Institute of Public Health And Environmental Sciences   (Japan)

^d NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PROTEIN S; VIRUS SPIKE PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; EPIDEMIOLOGY; GENE DELETION; GENE MUTATION; HEPATITIS VIRUS; HUMAN; HUMAN CELL; IMMUNITY; IMMUNIZATION; JAPAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RECEPTOR BINDING; SEROCONVERSION; SERODIAGNOSIS; VESICULAR STOMATITIS VIRUS; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN;

ADULT; AMINO ACID MOTIFS; ANTIBODIES, VIRAL; CELL LINE; CORONAVIRUS 229E, HUMAN; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; JAPAN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEUTRALIZATION TESTS; PHYLOGENY; SEQUENCE DELETION; VIRAL ENVELOPE PROTEINS; YOUNG ADULT;

EID: 84865147402     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.043117-0     Document Type: Article

References (37)

1. Bonavia, A., Zelus, B. D., Wentworth, D. E., Talbot, P. J. & Holmes, K. V. (2003). Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J Virol 77, 2530- 2538.
2. Cavanagh, D., Davis, P. J., Darbyshire, J. H. & Peters, R. W. (1986). Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutinationinhibiting antibody, or induce chicken tracheal protection. J Gen Virol 67, 1435-1442.
3. Chibo, D. & Birch, C. (2006). Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains. J Gen Virol 87, 1203-1208.
4. DePolo, N. J., Reed, J. D., Sheridan, P. L., Townsend, K., Sauter, S. L., Jolly, D. J. & Dubensky, T. W., Jr (2000). VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2, 218-222.
5. Dijkman, R., Jebbink, M. F., El Idrissi, N. B., Pyrc, K., Müller, M. A., Kuijpers, T. W., Zaaijer, H. L. & van der Hoek, L. (2008). Human coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol 46, 2368-2373.
6. Fukushi, S., Mizutani, T., Saijo, M., Matsuyama, S., Miyajima, N., Taguchi, F., Itamura, S., Kurane, I. & Morikawa, S. (2005). Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 86, 2269-2274.
7. Godet, M., Grosclaude, J., Delmas, B. & Laude, H. (1994). Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J Virol 68, 8008-8016.
8. Hamre, D. & Procknow, J. J. (1966). A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 121, 190-193.
9. Hirokawa, C., Watanabe, K., Kon, M., Tamura, T. & Nishikawa, M. (2008). Isolation of a virus closely related to human coronavirus 229E from a case of pharyngitis, March 2008-Niigata. Infectious Agents Surveillance Report 29, 283 (in Japanese).
10. Holmes, K. V. & Compton, S. R. (1995). Coronavirus receptors. In The Coronaviridae, pp. 55-71. Edited by S. G. Siddell. New York: Plenum Press.
11. Ishii, K., Hasegawa, H., Nagata, N., Ami, Y., Fukushi, S., Taguchi, F. & Tsunetsugu-Yokota, Y. (2009). Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. Microbiol Immunol 53, 75-82.
12. Kawase, M., Shirato, K., Matsuyama, S. & Taguchi, F. (2009). Protease-mediated entry via the endosome of human coronavirus 229E. J Virol 83, 712-721.
13. Kubo, H., Takase-Yoden, S. & Taguchi, F. (1993). Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variant. J Gen Virol 74, 1421-1425.
14. Kubo, H., Yamada, Y. K. & Taguchi, F. (1994). Localization of neutralizing epitopes and the receptor-binding site within the aminoterminal 330 amino acids of the murine coronavirus spike protein. J Virol 68, 5403-5410.
15. Lai, M. M. (1990). Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol 44, 303-333.
16. Lai, M. M. & Cavanagh, D. (1997). The molecular biology of coronaviruses. Adv Virus Res 48, 1-100.
17. Lamarre, A. & Talbot, P. J. (1995). Protection from lethal coronavirus infection by immunoglobulin fragments. J Immunol 154, 3975-3984.
18. Madu, I. G., Roth, S. L., Belouzard, S. & Whittaker, G. R. (2009). Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol 83, 7411-7421.
19. Matsuyama, S., Ujike, M., Morikawa, S., Tashiro, M. & Taguchi, F. (2005). Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A 102, 12543-12547.
20. Mills, B. J. & Cooper, N. R. (1978). Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements. J Immunol 121, 1549-1557.
21. Mills, B. J., Beebe, D. P. & Cooper, N. R. (1979). Antibodyindependent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis. J Immunol 123, 2518- 2524.
22. Niesters, H. G., Kusters, J. G., Lenstra, J. A., Spaan, W. J., Horzined, M. C. & van der Zeijst, B. A. (1987). The neutralization epitopes on the spike protein of infectious bronchitis virus and their antigenic variation. Adv Exp Med Biol 218, 483-492.
23. Peiris, J. S., Guan, Y. & Yuen, K. Y. (2004). Severe acute respiratory syndrome. Nat Med 10 (Suppl.), S88-S97.
24. Qiu, Z., Hingley, S. T., Simmons, G., Yu, C., Das Sarma, J., Bates, P. & Weiss, S. R. (2006). Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol 80, 5768-5776.
25. Rockx, B., Donaldson, E., Frieman, M., Sheahan, T., Corti, D., Lanzavecchia, A. & Baric, R. S. (2010). Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J Infect Dis 201, 946-955.
26. Sayaka, T.-Y., Tateki, K., Siddell, S. G. & Taguchi, F. (1991). Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein. Virus Res 18, 99-107.
27. Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J. & Bates, P. (2004). Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoproteinmediated viral entry. Proc Natl Acad Sci U S A 101, 4240-4245.
28. Spaan, W., Cavanagh, D. & Horzinek, M. C. (1988). Coronaviruses: structure and genome expression. J Gen Virol 69, 2939-2952.
29. Sturman, L. S., Ricard, C. S. & Holmes, K. V. (1985). Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J Virol 56, 904-911.
30. Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. S., Olurinde, M. & other authors (2004). Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 101, 2536-2541.
31. Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A. & Kawaoka, Y. (1997). A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94, 14764-14769.
32. Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596-1599.
33. Menneigline van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J., Wolthers, K. C., Wertheim-van Dillen, P. M., Kaandorp, J., Spaargaren, J. & Berkhout, B. (2004). Identification of a new human coronavirus. Nat Med 10, 368-373.
34. Woo, P. C., Lau, S. K., Chu, C. M., Chan, K. H., Tsoi, H. W., Huang, Y., Wong, B. H., Poon, R. W., Cai, J. J. & other authors (2005). Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79, 884-895.
35. Yamada, Y. K., Takimoto, K., Yabe, M. & Taguchi, F. (1997). Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology 227, 215-219.
36. Yoshikawa, T., Hill, T. E., Yoshikawa, N., Popov, V. L., Galindo, C. L., Garner, H. R., Peters, C. J. & Tseng, C. T. (2010). Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS ONE 5, e8729.
37. Yoshikura, H. & Tejima, S. (1981). Role of protease in mouse hepatitis virus-induced cell fusion. Studies with a cold-sensitive mutant isolated from a persistent infection. Virology 113, 503-511.